Pharmaceutical

MorphoSys gets grant for novel compounds for treating diseases associated with methyl modifying enzymes

Discover a groundbreaking patent by MorphoSys AG for novel compounds targeting methyl modifying enzymes in cancer treatment. Learn about Formula (I) compounds and their potential impact on various types of cancer.

Apr 11, 2024 - 00:00
Discover a groundbreaking patent by MorphoSys AG for novel compounds targeting methyl modifying enzymes in cancer treatment. Learn about Formula (I) compounds and their potential impact on various types of cancer.
Read the original article

Tags:

Previous Article

Acceleron Pharma gets grant for treatment of spinal muscular atrophy using ALK4:...

Next Article

ADMA Biologics gets grant for treatment of upper respiratory tract infection wit...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: I grew up in one of Africa’s largest informal settlements. Now I’m helping heal it

Opinion: I grew up in one of Africa’s largest informal ...

Nov 25, 2023

STAT+: Here are the worst biopharma CEOs of 2023

STAT+: Here are the worst biopharma CEOs of 2023

Dec 19, 2023

STAT+: Fatty liver disease was alleviated by Lilly’s ‘triple-G’ obesity drug in small study

STAT+: Fatty liver disease was alleviated by Lilly’s ‘t...

Jun 26, 2023